- MST1R as a potential new target antigen of chimeric antigen receptor T cells to treat solid tumors
-
An W, Kang JS, Oh S, Tu A
- KMID: 2541636
- Korean J Physiol Pharmacol.
- 2023 May;27(3):241-256.
- doi: 10.4196/kjpp.2023.27.3.241
Although chimeric antigen receptor T cell (CAR-T) is a promising immunotherapy in hematological malignancies, there remain many obstacles to CART cell therapy for solid tumors. Identifying appropriate tumor-associated antigens (TAAs)... -
- CITED
-
- Close
- SHARE
-
- Close
